In human and experimentally modeled IBD, the reduced vascularization induced by VEGF decreases the delivery of inflammatory cells to colonic injury sites, thereby disrupting the damaging inflammation-angiogenesis cycle. The gene discussed is VEGFA; the disease is inflammatory bowel disease.